ClinicalTrials.gg
Active, not recruitingNCT03930056Updated Dec 24, 2025

C-Brace II Spinal Cord Injury

An interventional study of C-Brace II and Traditional Care KAFO intervention in Spinal Cord Injury, sponsored by Shirley Ryan AbilityLab. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-24.

Sponsored by Shirley Ryan AbilityLab · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 45 studies in Spinal Cord Injuries by Shirley Ryan AbilityLab — 12 open to participants now, 18 under way, none of them phase 3. Spinal Cord Injuries · Shirley Ryan AbilityLab.

Planned enrollment
27th of 42
30 · median 45
Started
2019
with 2 others
No phase
33 of 45
8 open now
Primary completion
2026-11
later than 9 of 17 live
Registered
26th of 45
by date

Among the 45 studies in Spinal Cord Injuries by Shirley Ryan AbilityLab, this one is the 27th largest by planned enrollment of the 42 interventional ones that give a count, is one of 3 that started in 2019, is one of 33 with no phase, reaches primary completion later than 9 of the 17 other live ones, and was the 26th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

12 of the 45 studies in Spinal Cord Injuries by Shirley Ryan AbilityLab are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 12 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 45 studies in Spinal Cord Injuries by Shirley Ryan AbilityLab, or all of them as a file.
02

Study summary

A randomized, repeated measures comparative design study to compare use of a micro-processor controlled knee-ankle-foot orthosis vs. traditional care knee-ankle-foot-orthosis (KAFO) models following discharge from inpatient rehabilitation.

03

Conditions studied

  • Spinal Cord Injury

Keywords

  • Orthotic
  • C-Brace
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

All participants:

Inclusion Criteria:

  • Be within 3-24 months post spinal cord injury diagnosis
  • 18-80 years
  • Must be able to demonstrate the ability to charge assigned sensors during 3-month home trial period on and off and sufficient memory ability to wear the devices each day during use of the orthoses.

Exclusion Criteria:

  • Unstable neurological, cardiovascular, or cancer diagnoses.
  • Cognitive impairments that limit study participation

In addition to the above inclusion criteria, the following criteria must be met to be designated into the study interventional tract (C-Brace II):

Inclusion criteria:

  • Requires orthotic bracing for lower extremity instability, including the knee joint, unilaterally or bilaterally

Exclusion criteria:

  • Body weight over 275 lbs
  • Flexion contracture in the knee and/or hip joint in excess of 10 degrees
  • Non-correctable knee varus/valgus in excess of 10 degrees
  • Moderate to severe spasticity
  • Leg length discrepancy in excess of 6" (15.24 cm)
  • Inability to stabilize the trunk with or without assistive devices (crutches, cane, etc.)
  • Inability to successfully use C-Brace trial tool in advancement of leg/s.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    C-Brace II Group

    Subjects will be assigned a C-Brace II orthotic for use.

    Device: C-Brace II

  • Active comparator
    Traditional Group

    Subjects will continue with their own KAFO (non C-Brace II) use.

    Device: Traditional Care KAFO intervention

Interventions

  • DeviceC-Brace II

    Participant will complete 3-6 orthoses sessions to complete clinical evaluations and fittings conducted by certified orthotists. Participant will receive 10-20, one hour training sessions over 1-2 months in the lab. These sessions include tuning the device and system tweaks in accordance to needs/preferences of participant, vitals signs, skin checks, pain, and exertion levels. Sessions involve training with the device, which includes putting on / taking off the device, transfer training, gait training, and balance and fall prevention. Up to 20 sessions will be conducted until minimum safety guidelines are reached during a minimum of at least 3 training sessions in a row. Participant will take the assigned device home to use for a 3-month period. Participant will be given an activity monitor to wear at all times except showering and instructed how to charge the device and use it. Participant will return for testing at 3, 6 and 12 months after receiving the brace for testing.

  • DeviceTraditional Care KAFO intervention

    Participant will continue with use of their own KAFO. Participant will receive 10-20, one hour training sessions over 1-2 months in the lab, if Patient is not already receiving care in a therapy setting. These sessions include tuning the device and system tweaks in accordance to needs/preferences of participant, vitals signs, skin checks, pain, and exertion levels. Sessions involve training with the device, which includes putting on / taking off the device, transfer training, gait training, and balance and fall prevention. Up to 20 sessions will be conducted until minimum safety guidelines are reached during a minimum of at least 3 training sessions in a row. Participant will continue with the assigned device home to use for a 3-month period. Participant will be given an activity monitor to wear at all times except showering and instructed how to charge the device and use it. Participant will return for testing at 3, 6 and 12 months after receiving the brace for testing.

06

What researchers measure

Primary outcomes

  1. Six Minute Walk Test (6MWT)

    The test measures the distance that the patient can walk on a flat, hard surface, indoors, in a period of 6 minutes. The walk test is patient self-paced and assesses the level of functional capacity. Patients are allowed to stop and rest during the test, however, the timer does not stop. If the patient is unable to complete the time, the time stopped is noted and reason for stopping prematurely is recorded. This test will be administered while wearing a mask to measure oxygen consumption.

    Time frame: Change from baseline in 6MWT distance after using device at 3, 6, and 12 month follow-up.

Secondary outcomes

  1. Muscle Strength (manual muscle test)

    Muscle strength will be assessed by a trained clinical researcher

    Time frame: Change from baseline in muscle strength after using device at 3, 6, and 12 month follow-up.

  2. Passive and Active Range of Motion of Lower Extremity joints

    Time frame: Change from baseline in range of motion after using device at 3, 6, and 12 month follow-up.

  3. Modified Ashworth Scale

    A scale used to measure the amount of tone in individuals with neurologic diagnoses. Tone is scored by passively moving the individual's limb and assessing the amount of resistance to movement felt by the examiner.

    Time frame: Change from baseline in muscle tone after using device at 3, 6, and 12 month follow-up.

  4. 10 Meter Walk Test (10MWT)

    This test will examine the patient's gait speed. Patients will be positioned 1 meter before the start line and instructed to walk the entire 10 meter distance and past the end line approximately 1 meter. The distance before and after the course are meant to minimize the effect of acceleration and deceleration. Time will be recorded using a stopwatch and recorded to the one hundred of a second (ex: 2.15 sec). The test will be recorded 6 times: 3 times at the patient's self-selected speed, and 3 times at the patient's quickest, yet safest speed. The average of each of the 3 times will be recorded. Adequate rest in between trials will be given.

    Time frame: Change from baseline in gait speed after using device at 3, 6, and 12 month follow-up.

  5. Walking Index for Spinal Cord Injury (WISCI II)

    A rank ordering along a dimension of impairment, from the level of most severe impairment (0) to least severe impairment (20) based on the use of devices, braces, and physical assistance of one or more persons.

    Time frame: Change from baseline in rank score after using device at 3, 6, and 12 month follow-up.

  6. Functional Gait Assessment (FGA)

    The Functional Gait Assessment is a 10 item test used to assess postural stability during walking tasks. It has a maximum score of 30 with each item being scored 0-3. It may be performed with or without an assistive device; however, individuals lose a point on all items requiring a device.

    Time frame: Change from baseline in FGA score after using device at 3, 6, and 12 month follow-up.

  7. Berg Balance Scale (BBS)

    The Berg Balance Scale is a 14-item scale designed to measure balance in adults in a clinical setting. When scoring, the lowest response category that applies should be recorded. In each item, points should be deducted if the time or distance requirements are not met, the subject's performance requires supervision, or the subject requires assistance from support or examiner.

    Time frame: Change from baseline in Berg Balance score after using device at 3, 6, and 12 month follow-up.

  8. Timed Up and Go test (TUG)

    A test which times the ability of a patient to stand up from a standard chair with arm rests, walk 3 meters forward, turn around, walk 3 meters back to the chair, and sit back down in the chair.

    Time frame: Change from baseline in TUG score after using device at 3, 6, and 12 month follow-up.

  9. Gaitrite data capture

    The Gaitrite system automates measuring temporal and spatial gait parameters via an electronic walkway connected to a computer. The Gaitrite electronic walkway contains sensor pads encapsulated in a carpet to collect gait information. The system can be laid over any flat surface. The Gaitrite electronic walkway for the study shall be a minimum of 14 feet long. The Gaitrite data capture was chosen as measurement of the patient's overall gait quality. Patients will be asked to walk at a self-selected speed across the Gaitrite electronic walkway.

    Time frame: Change from baseline in gait parameters after using device at 3, 6, and 12 month follow-up.

Other outcomes

  1. Activities Specific Balance Confidence Scale (ABC)

    The ABC Scale is a self-report questionnaire consisting of 16 items designed to measure fear of falling. It assesses an individual's perception of balance during activities of daily living by asking the individual to rate their confidence during different activities on a 0% (no confidence) to 100% (completely confident) scale.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  2. Modified Falls Efficacy Scale (mFES)

    The mFES is self-report questionnaire consisting of 14 items which is designed to measure fear of falling in the elderly. It assesses an individual's perception of balance during activities of daily living by asking "how confident are you that you can do the following activities without falling."

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  3. Spinal Cord Injury Quality of Life (SCI-QOL)

    The SCI-QOL are a battery of self-reported questionnaires completed by participants to evaluate perceptions of personal independence, ability to communicate needs with others, and sense of control over one's life in individuals with spinal cord injury.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  4. EQ5D-5L

    A self-reported, health related, quality of life questionnaire. It measures quality of life in 5-components including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each level is rated on a scale describing the degree of problems in that area. It ends with an overall health scale between 1-100 to rate the level of health the user is experiencing at the time of the test.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  5. Orthotics and Prosthetics User Survey (OPUS)

    The Orthotic and prosthetics User Survey is a self-report questionnaire which is designed to evaluate the outcome of orthotic and prosthetic services. We will administer three of the five domains: lower limb functional measure, health-related quality of life, and satisfaction with device. The domains of upper limb functional measure and satisfaction with service are not applicable in this study.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  6. World Health Organization Quality of Life (WHOQOL-BREF)

    The WHOQOL-BREF is a self-report questionnaire that measures an individual's perceived quality of life. It contains four domains which cover physical health, psychological health, social relationships, and environment. Scores range from 0-100 with 100 indicating a higher quality of life. The scores can be broken down by domain or taken as a whole. The WHOQOL-BREF is valid cross-culturally.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  7. International Spinal Cord Injury Bowel Function Data Set

    The purpose of this test is to standardize collection and reporting on the bowel in individuals with spinal cord injury. Questions include bowel care procedures, surgical procedures, time, frequency, and method of bowel practices.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  8. International Spinal Cord Injury Lower urinary Tract Basic Data Set

    The purpose of this test is to standardize collection and reporting of information on the lower urinary tract in individuals with spinal cord injury. Questions include surgical procedures, drugs, bladder emptying, and incontinence. These are used by clinicians and researchers so that data can be shared and combined easily.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  9. Spinal Cord Injury Bowel and Bladder Treatment Index Short Form (SCI-BBTI-SF)

    A self-report questionnaire that assesses bowel and bladder function. It includes items regarding bowel and bladder emptying habit, complications from SCI-related surgery, assistance required, and perceived quality of life.

    Time frame: Change from baseline in score after using device at 3, 6, and 12 month follow-up.

  10. Actigraph

    The Actigraph is a small accelerometer worn on a body part which can identify performance of functional activities during use.

    Time frame: Change from baseline measurement after using device at 3, 6, and 12 month follow-up.

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2019 (actual). Primary completion is estimated for Nov 2026, 91 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 91 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 25, 2019
First posted
Apr 29, 2019
StartActual
Apr 16, 2019
Primary completionEst.
Nov 2026
CompletionEst.
Nov 2026
Last update
Dec 24, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03930056
Collaborators
Otto Bock Healthcare Products GmbH
Responsible party
Arun Jayaraman, PT, PhD (Research Scientist, Shirley Ryan AbilityLab) — Principal investigator
First posted
Apr 29, 2019
Start date
Apr 16, 2019
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Dec 24, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion